首页 | 本学科首页   官方微博 | 高级检索  
     

癌基因HER2与乳腺癌的治疗
引用本文:陈灿铭,沈镇宙,邵志敏. 癌基因HER2与乳腺癌的治疗[J]. 中国癌症杂志, 2000, 10(5): 446-448
作者姓名:陈灿铭  沈镇宙  邵志敏
作者单位:复旦大学医学院附属肿瘤医院乳腺外科,上海,200032
摘    要:HER2/c-erbB2是编码一种生长因子受体(p185^HER2)的癌基因,研究发现HER2基因的扩增和表达对于乳腺癌的预后具有重要意义,对于乳腺癌的治疗亦有重要的指导作用。针对p185^HER2的单克隆抗体Herceptin能有效抑制p185^HER2高表达的乳腺癌细胞的生长,为乳腺癌的治疗提供了一种新的手段。而针对HER2表达产物p185^HER2的疫苗的研究将可能是乳腺癌治疗的一个重要的突

关 键 词:HER2 p185^HER2 Herceptin 乳腺癌 疫苗 癌基因
文章编号:1007-3639(2000)05-0446-03
修稿时间:2000-07-14

HER2 and treatment of breast cancer
CHEN Can ming,SHEN Zhen zhou,SHAO Zhi min. HER2 and treatment of breast cancer[J]. China Oncology, 2000, 10(5): 446-448
Authors:CHEN Can ming  SHEN Zhen zhou  SHAO Zhi min
Abstract:HER2/c erbB2 is a human oncogene which encodes a 185 kDa transmembrane glycoprotein receptor (p185 HER2 ). The amplification and overexpression of HER2 have a major role in the treatment and the prognosis of breast cancer. The antibody to the p185 HER2 ,Herveptin,can potently inhibit the growth of human breast cancer that overexpress p185 HER2 , which provides a new measure for the treatment of breast cancer. The research of vaccine to p185 HER2 for breast cancer may be a breakthrough in the treatment of breast cancer.
Keywords:HER2  p185 HER2  herceptin  breast cancer  vaccine
本文献已被 CNKI 维普 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号